Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Enterprise Value (2019 - 2026)

Viatris (VTRS) posted Enterprise Value of $17.4 billion for Q2 2026, up 24.58% on a QoQ basis from $13.9 billion in Q1 2026, and up 76.27% year-over-year from $9.8 billion in Q2 2025.

Analysis

Viatris (VTRS) Enterprise Value (2019 - 2026) Analysis & Trends

Viatris has reported Enterprise Value for 8 years, with the latest figure at $17.4 billion in Q2 2026.

  • On a quarterly basis, Enterprise Value rose 76.27% year-over-year to $17.4 billion in Q2 2026; TTM through Jun 2026 was $17.4 billion, a 76.27% increase from a year earlier, with the FY2025 full-year figure at $13.0 billion, down 7.88% from the prior year.
  • Enterprise Value was $17.4 billion for Q2 2026 at Viatris, up from $13.9 billion in the prior quarter.
  • The five-year high for Enterprise Value was $17.4 billion in Q2 2026, with the low at $9.5 billion in Q1 2025.
  • Average Enterprise Value over 5 years is $12.0 billion, with a median of $11.9 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2026: Enterprise Value tumbled 38.04% in 2022, then soared 76.27% in 2026.
  • Over 5 years, Enterprise Value stood at $12.1 billion in 2022, then fell by 1.56% to $11.9 billion in 2023, then rose by 19.01% to $14.1 billion in 2024, then dropped by 7.88% to $13.0 billion in 2025, then jumped by 33.36% to $17.4 billion in 2026.
  • The last three Enterprise Value figures came in at $17.4 billion (Q2 2026), $13.9 billion (Q1 2026), and $13.0 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.35 Bn
Mar 31, 2026 13.93 Bn
Dec 31, 2025 13.01 Bn
Sep 30, 2025 10.43 Bn
Jun 30, 2025 9.84 Bn
Mar 31, 2025 9.47 Bn
Dec 31, 2024 14.13 Bn
Sep 30, 2024 11.98 Bn
Jun 30, 2024 11.77 Bn
Mar 31, 2024 13.20 Bn
Dec 31, 2023 11.87 Bn
Sep 30, 2023 10.52 Bn
Jun 30, 2023 11.34 Bn
Mar 31, 2023 11.03 Bn
Dec 31, 2022 12.06 Bn
Sep 30, 2022 9.69 Bn
Jun 30, 2022 12.03 Bn
Mar 31, 2022 12.44 Bn
Dec 31, 2021 15.66 Bn
Sep 30, 2021 15.63 Bn